NCT04032756View on ClinicalTrials.gov

Tofacitinib Registry of Patients With Ulcerative Colitis in Germany

TerminatedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

November 15, 2020

Study Completion Date

November 15, 2020

Conditions
Colitis, UlcerativeBiologicsTofacitiniibChronic Inflammatory Small Bowel DiseaseBowel Diseases, InflammatoryBowel DiseaseCED
Trial Locations (1)

32423

Gastroenterologische Gemeinschaftspraxis Minden, Minden

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Ced Service GmbH

OTHER

NCT04032756 - Tofacitinib Registry of Patients With Ulcerative Colitis in Germany | Biotech Hunter | Biotech Hunter